未登录

T

Talía Malagón

mcgill university

H指数:18

被引数:1,485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differences in age at diagnosis of breast cancer largely attributable to different age structures

乳腺癌诊断年龄的差异主要归因于不同的年龄结构

IF4.2

2026-07-310

OAAI

Inequalities in relative cancer survival by race, immigration status, income, and education for 22 cancer sites in Canada, a cohort study

加拿大22个癌症站点的种族，移民身份，收入和教育程度的相对癌症生存率不平等，一项队列研究

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2025-01-160

OA

Time to change the paradigm for primary endpoints in cancer screening trials?

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2024-05-230

OA

Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination

流行病学HPV相关癌症的过去、现在和未来: 预防和消除

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2024-05-1717

PRE

Evaluating chemotherapy receipt and candidacy for PARP inhibitors in germline BRCA1/2 carriers with early and locally advanced breast cancer

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5 a Groupe de Radio-Oncologie Genito-Urinaire de Quebec Led Phase 3 Trial

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2024-01-019

PRE

Betapapillomavirus natural history and co-detection with alphapapillomavirus in cervical samples of adult women

成年女性宫颈样本中 β-乳头状瘤病毒的自然史和与 α-乳头状瘤病毒的共同检测

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-12-060

OAAI

Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis

INFECTIOUS AGENTS AND CANCER

IF2.8

2023-11-088

OAAI

Differences in site-specific cancer incidence by individual- and area-level income in Canada from 2006 to 2015

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2023-07-263

OA

Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2023-02-159

OA

Site-Specific Cancer Incidence by Race and Immigration Status in Canada 2006-2015: A Population-Based Data Linkage Study

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2023-02-149

OA

Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2021-12-0389

OA

Proportion of Incident Genital Human Papillomavirus Detections not Attributable to Transmission and Potentially Attributable to Latent Infections: Implications for Cervical Cancer Screening

CLINICAL INFECTIOUS DISEASES

IF7.3

2021-11-2812

OA

Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination

JAMA NETWORK OPEN

IF9.7

2021-06-3011

OAAI

Sexual Network Patterns and Their Association With Genital and Anal Human Papillomavirus Infection in Adolescent and Young Men

JOURNAL OF ADOLESCENT HEALTH

IF4.5

2021-04-014

OAAI

Reply to: Comments on cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2021-02-190

OAAI

Invited Commentary: Rethinking Cervical Cancer Elimination in Terms of Lifetime Risk Rather Than Arbitrarily Defined Age-Standardized Incidence Rates

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2020-07-083

PREAI

Modeling the Balance of Benefits and Harms of Cervical Cancer Screening with Cytology and Human Papillomavirus Testing

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2020-07-011

PREAI

Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2020-05-2620

OAAI

Reasons for optimism about eliminating cervical cancer in China

LANCET PUBLIC HEALTH

IF25.2

2019-09-017

OAAI